The degron is therefore more affected by somatic SETBP1 mutations that promote cancer than by germline mutations that cause SGS, implying that the threshold for cancer caused by mutations in the SETBP1 degron is higher than that for prenatal developmental alterations in SGS. This evidence concerns the gene SETBP1 and cancer.